In Brief Huntsman Cancer Institute adds second Mevion S250i proton therapy system September 12, 2025Vol.51 No.33
In Brief Northwestern Medicine to adopt “David,” a generative AI copilot by Tempus AI Inc. September 12, 2025Vol.51 No.33
Clinical Roundup Rybrevant + Lazcluze block resistance, extend survival in first-line EGFR-mutated NSCLC, phase III trial shows September 12, 2025Vol.51 No.33
Clinical Roundup Tagrisso + chemo demonstrate OS benefit in EGFR-mutated NSCLC, phase III trial shows September 12, 2025Vol.51 No.33
Clinical Roundup Padcev + Keytruda reach primary endpoint for some bladder cancers, phase III trial shows September 12, 2025Vol.51 No.33
Clinical Roundup NeXT Personal MRD test predicts NSCLC outcomes, phase III trial shows September 12, 2025Vol.51 No.33
Clinical Roundup Pre- and post-surgery immunotherapy combination shows promise for mesothelioma, Johns Hopkins-led study shows September 12, 2025Vol.51 No.33
Clinical Roundup New genetic biomarker flags aggressive brain tumors, Mayo Clinic study finds September 12, 2025Vol.51 No.33
